id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1226-0007,FDA,FDA-2012-E-1226,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2015-03-10T04:00:00Z,2015,3,2015-03-10T04:00:00Z,,2024-03-12T12:12:51Z,,0,0,0900006481a381c2
FDA-2012-E-1226-0006,FDA,FDA-2012-E-1226,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PICATO",Notice,General Notice,2014-05-20T04:00:00Z,2014,5,2014-05-20T04:00:00Z,,2014-05-20T14:10:27Z,2014-11521,0,0,0900006481705835
FDA-2012-E-1226-0005,FDA,FDA-2012-E-1226,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2014-05-12T04:00:00Z,2014,5,2014-05-12T04:00:00Z,,2024-03-12T12:12:42Z,,0,0,09000064816f29c3
FDA-2012-E-1226-0004,FDA,FDA-2012-E-1226,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-28T04:00:00Z,2014,3,2014-03-28T04:00:00Z,,2014-03-28T19:53:13Z,,0,0,090000648168cf76
FDA-2012-E-1226-0003,FDA,FDA-2012-E-1226,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2013-02-22T05:00:00Z,2013,2,2013-02-22T05:00:00Z,,2024-03-11T18:29:45Z,,0,0,0900006481203a3e
FDA-2012-E-1226-0002,FDA,FDA-2012-E-1226,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:14:08Z,,0,0,090000648119ce85
FDA-2012-E-1226-0001,FDA,FDA-2012-E-1226,"LEO Laboratories (Edwards, Wildman, Palmer LLP) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:11:19Z,,0,0,090000648119ce83